Technicals
I also hold BTA and am obviously biased, but despite the dramatic drop over the last 12 months after the equally sharp rise, without even looking at the med-long term prospects of this stock as their next gen flu drug goes live ROW over the next 1-2 yrs (or even earlier with emergency approvals), there is plenty more upside at the moment than any downside that I can see.
